On March 26, the IOC published a document outlining its new policies regarding the participation of transgender women in Olympic competitions. These new regulations will apply starting with the Los Angeles Olympic Games in 2028 and are not retroactive.

The document states that only women (with female biological sex) may participate in the women’s category competitions of the Olympic Games or any other event of the Olympic Committee, both in individual and team competitions.

Eligibility to compete in the women’s category will be determined by an SRY gene screening to detect the presence of the SRY gene, which determines that a person is male.

It is a simple test carried out using a saliva sample, a buccal swab or a blood sample; it is done just once and is valid for life.

This means that female athletes who test negative for the SRY gene will be able to compete in women’s competitions.

Exceptions to this rule include athletes who suffer from Complete Androgen Insensitivity Syndrome (CAIS) or other rare differences/disorders in sex development (DSDs), who do not benefit from the enhancing effects of testosterone.

Athletes with a positive SRY screen are eligible for any male or mixed category, or in sports that do not classify athletes by sex.

The working group that drafted the document has reviewed the latest scientific evidence and concluded that men have a competitive advantage over women in all sports in terms of strength, power and endurance.

According to the IOC, this new policy safeguards equal opportunities for female athletes in competitions, enhances Olympic value and increases visibility for the female category.

Background

In September 2025, the US Olympic Committee already banned the participation of “trans women,” that is, biological males who had transitioned to the female gender, in women’s competitions.

Until now, the International Olympic Committee allowed each sports federation to decide whether trans athletes could compete in international events.

Previously, both World Aquatics and World Athletics had already banned trans women from competing in women’s categories.

In 2023, Sebastian Coe, Olympic champion and director of World Athletics, stated that “we must maintain fairness for female athletes above all other considerations. We will be guided in this by the science around physical performance and male advantage which will inevitably develop over the coming years. As more evidence becomes available, we will review our position, but we believe the integrity of the female category in athletics is paramount.”

Bioethical Assessment

The conflicts arising from the establishment of the premises defended by gender ideology stem from a lack of scientific basis. The confusion created in the treatment of the concepts of sex and gender, which promotes their dissociation, generates unfair comparisons when desire ignores the biological condition that every human being possesses, specifically their sexed nature.

The sexual configuration of individuals of the human species, as in many other species, is determined by the genetic combination of the genomes of the male and female gametes at the time of fertilization.

Thus, from the zygote stage – a single-celled individual of the human species – sex is determined not only by the presence of the SRY gene (Sex determining Region Y), located in region 1 of the short arm of the Y chromosome, and primarily responsible for the development of male sexual characteristics in mammals.

This gene determines the masculinization process in the seventh week of gestation. But other genes are also involved in sexual differentiation, such as the Tfm gene, located on the X chromosome, which encodes the receptor for male hormones, or the ODF region of the X chromosome, which promotes ovary development and inhibits testicular development.

During embryonic development, the activation of certain sex-specific genes leads to the silencing of their homologues on the opposite sex’s chromosome: the H19 gene is silenced on the paternal chromosome and the Igf2 gene is silenced on the maternal one (epigenetic mechanisms).

Other genes, located on different chromosomes, are involved in sexual differentiation. For example, the gene that encodes for the synthesis of anti-Müllerian hormone by Sertoli cells in the testis is on the short arm of chromosome 19. The Gadd45g gene, located on chromosome 9, is crucial for masculinization and interacts with the SRY gene.

In addition, another gene, WNT4, located on the short arm of chromosome 1, encodes a protein important for the formation of the female reproductive system, kidneys, and several hormone-producing glands. The protein it encodes regulates the formation of the Müllerian ducts, which give rise to the uterus, ovaries, fallopian tubes, cervix, and upper part of the vagina.

Sex-specific gene expression also plays a key role in sexual development. In one study, around 6,500 human protein-coding genes were identified that are expressed differently in males and females.

This study establishes that sexually dimorphic traits result primarily from the differential expression of genes present in both sexes. These genes may be subject to different, and even opposing, selection constraints in the two sexes.

From all this it follows that the genetic heritage that defines sex in humans is complex and multifactorial, with a multitude of genes involved, which constitute the two phenotypic expressions male and female.

Various alterations in the genetic makeup that defines sex can lead to Disorders of Sex Development (DSD), resulting in incomplete gonadal development or phenotypic characteristics of both sexes. These constitute, in any case, rare exceptions to the biological norm of sexual differentiation.

Thus, these infrequent disorders of sexual development must be differentiated from the transition processes in transsexuals, requiring individualized analysis and assessment.

Ignoring the biological differences between the sexes can lead to discrimination in sports competition, where some developmental characteristics present significant differences.

This shouldn’t be linked to discriminatory practices, because what is discriminatory is demanding the same level of performance under very different physiological conditions. This is something that has always been avoided by creating male and female categories in sports competitions where these differences significantly affect performance.

Julio Tudela and Ester Bosch

Bioethics Observatory – Institute of Life Sciences

Catholic University of Valencia

Share This Story, Choose Your Platform!